First peanut allergy treatment gains backing from FDA advisory panel – Science Magazine
By Jennifer Couzin-FrankelSep. 13, 2019 , 5:15 PM After 8 hours of contentious discussion, an advisory committee to the U.S. Food and Drug Administration (FDA) today endorsed the effectiveness of a first-of-its-kind peanut allergy treatment. By a seven-to-two vote, the panel concluded that the treatment, known as AR101, can reduce allergic reactions from accidental exposure to… Read More: First peanut allergy treatment gains backing from FDA advisory panel… »